Other
Oocyte Maturation
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Oocyte Maturation is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Completed6 · 50%
Unknown status4 · 33%
Not yet recruiting1 · 8%
Terminated1 · 8%
Clinical Trials
Trial Activity
12 trials
Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles
Completed·—·Phase 4·NCT00627406·384 enrolled
Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders
Completed·—·Phase 3·NCT04224818·140 enrolled
COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES
Unknown status·—·Phase 3·NCT05397795·160 enrolled
Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients
Unknown status·—·Phase 2·NCT01973842·90 enrolled
Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger
Unknown status·—·Phase 2·NCT06146413·150 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)